- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7007
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A phenomics approach for antiviral drug discovery ; volume:19 ; number:1 ; day:2 ; month:8 ; year:2021 ; pages:1-15 ; date:12.2021
BMC biology ; 19, Heft 1 (2.8.2021), 1-15, 12.2021
- Urheber
-
Rietdijk, Jonne
Tampere, Marianna
Pettke, Aleksandra
Georgiev, Polina
Lapins, Maris
Warpman-Berglund, Ulrika
Spjuth, Ola
Puumalainen, Marjo-Riitta
Carreras-Puigvert, Jordi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12915-021-01086-1
- URN
-
urn:nbn:de:101:1-2021102720154528866749
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rietdijk, Jonne
- Tampere, Marianna
- Pettke, Aleksandra
- Georgiev, Polina
- Lapins, Maris
- Warpman-Berglund, Ulrika
- Spjuth, Ola
- Puumalainen, Marjo-Riitta
- Carreras-Puigvert, Jordi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Virus-host interactomics: new insights and opportunities for antiviral drug discovery
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
Antiviral drug strategies
A microfluidics-based approach to drug discovery
A dual controllability analysis of influenza virus-host protein-protein interaction networks for antiviral drug target discovery
Repurpsing Antiviral Drugs for Orthogonal RNA-Catalyzed Labeling
Epigenetic drug discovery
Successful Drug Discovery
In vivo models for drug discovery
Machine Learning for Kinase Drug Discovery
Molecular Fragment Mining for Drug Discovery
Green chemistry strategies for drug discovery
Virus-host interactomics: new insights and opportunities for antiviral drug discovery
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
Antiviral drug strategies
A microfluidics-based approach to drug discovery
A dual controllability analysis of influenza virus-host protein-protein interaction networks for antiviral drug target discovery
Repurpsing Antiviral Drugs for Orthogonal RNA-Catalyzed Labeling
Epigenetic drug discovery
Successful Drug Discovery
In vivo models for drug discovery
Machine Learning for Kinase Drug Discovery
Molecular Fragment Mining for Drug Discovery
Green chemistry strategies for drug discovery
Virus-host interactomics: new insights and opportunities for antiviral drug discovery
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
Antiviral drug strategies
A microfluidics-based approach to drug discovery
A dual controllability analysis of influenza virus-host protein-protein interaction networks for antiviral drug target discovery
Repurpsing Antiviral Drugs for Orthogonal RNA-Catalyzed Labeling
Epigenetic drug discovery
Successful Drug Discovery
In vivo models for drug discovery
Machine Learning for Kinase Drug Discovery
Molecular Fragment Mining for Drug Discovery